open access

Vol 94, No 9 (2023)
Review paper
Published online: 2022-11-24
Get Citation

Depression and anxiety in patients with pelvic floor disorders

Urszula Kalata1, Michal M. Jarkiewicz2, Ewa M. Barcz3
·
Pubmed: 36448346
·
Ginekol Pol 2023;94(9):748-751.
Affiliations
  1. Multidisciplinary Hospital Warsaw Miedzylesie, Warsaw, Poland, Poland
  2. Institute of Psychiatry and Neurology, 3rd Department of Psychiatry, Warsaw, Poland, Poland
  3. Chair of Gynecology and Obstetrics Faculty of Medicine, University of Cardinal Stefan Wyszynski, Warsaw, Poland, Poland

open access

Vol 94, No 9 (2023)
REVIEW PAPERS Gynecology
Published online: 2022-11-24

Abstract

Pelvic floor disorders are very common health problems in adult women affecting their quality of life in many aspects. One of them, still poorly recognised, is depression as well as anxiety. As the main goal of treatment is achievement of improvement of life quality we have to be aware of the incidence and severity of mood disorders in urogynecological patients. It is very important to be sure whether treatment of main disease is enough to solve depression and anxiety or we have to cope with them separately. The review sums up current knowledge on that very important topic.

Abstract

Pelvic floor disorders are very common health problems in adult women affecting their quality of life in many aspects. One of them, still poorly recognised, is depression as well as anxiety. As the main goal of treatment is achievement of improvement of life quality we have to be aware of the incidence and severity of mood disorders in urogynecological patients. It is very important to be sure whether treatment of main disease is enough to solve depression and anxiety or we have to cope with them separately. The review sums up current knowledge on that very important topic.

Get Citation

Keywords

depression; anxiety; stress urinary incontinence; overactive bladder syndrome; pelvic organ prolapse

About this article
Title

Depression and anxiety in patients with pelvic floor disorders

Journal

Ginekologia Polska

Issue

Vol 94, No 9 (2023)

Article type

Review paper

Pages

748-751

Published online

2022-11-24

Page views

790

Article views/downloads

865

DOI

10.5603/GP.a2022.0130

Pubmed

36448346

Bibliographic record

Ginekol Pol 2023;94(9):748-751.

Keywords

depression
anxiety
stress urinary incontinence
overactive bladder syndrome
pelvic organ prolapse

Authors

Urszula Kalata
Michal M. Jarkiewicz
Ewa M. Barcz

References (26)
  1. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258): 1204–1222.
  2. Zhao Y, Hu Y, Smith JP, et al. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014; 43(1): 61–68.
  3. Pan A, Keum N, Okereke OI, et al. Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care. 2012; 35(5): 1171–1180.
  4. Mezuk B, Eaton WW, Albrecht S, et al. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008; 31(12): 2383–2390.
  5. Lippi G, Montagnana M, Favaloro EJ, et al. Mental depression and cardiovascular disease: a multifaceted, bidirectional association. Semin Thromb Hemost. 2009; 35(3): 325–336.
  6. Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003; 20(6): 327–336.
  7. Raquel H, Alves AT, Garcia PA, et al. Risk factors for mild depression in older women with overactive bladder syndrome — A cross sectional study. PLoS One. 2020; 15(1): e0227415.
  8. Melotti IG, Juliato CR, Coelho SC, et al. Is there any difference between depression and anxiety in overactive bladder according to sex? A systematic review and meta-analysis. Int Neurourol J. 2017; 21(3): 204–211.
  9. Coyne KS, Sexton CC, Kopp ZS, et al. The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS. BJU Int. 2011; 108(9): 1459–1471.
  10. Melotti IG, Juliato CR, Tanaka M, et al. Severe depression and anxiety in women with overactive bladder. Neurourol Urodyn. 2018; 37(1): 223–228.
  11. Jacomo RH, Alves AT, Garcia PA, et al. Risk factors for mild depression in older women with overactive bladder syndrome — A cross sectional study. PLoS One. 2020; 15(1): e0227415.
  12. Shiozawa A, Hopson S, Fuldeore R, et al. Increased healthcare resource utilization and direct and indirect costs in patients with depression and comorbid overactive bladder: evidence from a retrospective, matched case-control cohort analysis. Adv Ther. 2020; 37(11): 4599–4613.
  13. Kim KS, Moon HS. Antimuscarinic agent treatment affecting patient-reported outcomes in overactive bladder syndrome with depressive symptoms. Int Neurourol J. 2016; 20(4): 349–355.
  14. Ahn KS, Hong HP, Kweon HJ, et al. Correlation between overactive bladder syndrome and obsessive compulsive disorder in women. Korean J Fam Med. 2016; 37(1): 25–30.
  15. Jurášková M, Piler P, Kukla L, et al. Association between stress urinary incontinence and depressive symptoms after birth: the czech ELSPAC study. Sci Rep. 2020; 10(1): 6233.
  16. Felde G, Bjelland I, Hunskaar S. Anxiety and depression associated with incontinence in middle-aged women: a large Norwegian cross-sectional study. Int Urogynecol J. 2012; 23(3): 299–306.
  17. Felde G, Ebbesen MH, Hunskaar S. Anxiety and depression associated with urinary incontinence. A 10-year follow-up study from the Norwegian HUNT study (EPINCONT). Neurourol Urodyn. 2017; 36(2): 322–328.
  18. Hansson Vikström N, Wasteson E, Lindam A, et al. Anxiety and depression in women with urinary incontinence using E-health. Int Urogynecol J. 2021; 32(1): 103–109.
  19. Zalewski M, Kołodyńska G, Fink-Lwow F, et al. The relationship between anxiety and depression levels and general health status before and 12 months after SUI treatment in postmenopausal women from the lower silesian population. Int J Environ Res Public Health. 2022; 19(9).
  20. Siddiqui NY, Wiseman JB, Cella D, et al. LURN. Mental health, sleep and physical function in treatment seeking women with urinary incontinence. J Urol. 2018; 200(4): 848–855.
  21. Kinjo M, Masuda K, Nakamura Yu, et al. Effects on depression and anxiety after mid-urethral sling surgery for female stress urinary incontinence. Res Rep Urol. 2020; 12: 495–501.
  22. Innerkofler PC, Guenther V, Rehder P, et al. Improvement of quality of life, anxiety and depression after surgery in patients with stress urinary incontinence: results of a longitudinal short-term follow-up. Health Qual Life Outcomes. 2008; 6: 72.
  23. Ghetti C, Lowder JL, Ellison R, et al. Depressive symptoms in women seeking surgery for pelvic organ prolapse. Int Urogynecol J. 2010; 21(7): 855–860.
  24. Pizarro-Berdichevsky J, Hitschfeld MJ, Pattillo A, et al. Association between pelvic floor disorder symptoms and QoL scores with depressive symptoms among pelvic organ prolapse patients. Aust N Z J Obstet Gynaecol. 2016; 56(4): 391–397.
  25. Larouche M, Brotto LA, Koenig NA, et al. Depression, anxiety, and pelvic floor symptoms before and after surgery for pelvic floor dysfunction. Female Pelvic Med Reconstr Surg. 2020; 26(1): 67–72.
  26. Collins AF, Doyle PJ, Duecy EE, et al. Do anxiety traits predict subjective short-term outcomes following prolapse repair surgery? Int Urogynecol J. 2019; 30(3): 417–421.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl